HROW Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 109446 min ago

@ $11.34

Ausgestellt: 13 Feb 2024 @ 21:41

Rendite: -6.35%

Vorheriges Signal: Feb 12 - 21:34

Vorheriges Signal: Kaufen

Rendite: -3.57 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:00):

Stats
Tagesvolumen	351 130
Durchschnittsvolumen	470 853
Marktkapitalisierung	375.55M
EPS	$0 ( 2024-03-28 )
Nächstes Ertragsdatum	( $-0.250 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.16
ATR14	$0.0140 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Opaleye Management Inc.	Buy	20 000	Common Stock, par value $0.001 per share
2024-04-24	Opaleye Management Inc.	Buy	8 285	Common Stock, par value $0.001 per share
2024-04-23	Opaleye Management Inc.	Buy	11 715	Common Stock, par value $0.001 per share
2024-04-19	Opaleye Management Inc.	Buy	29 400	Common Stock, par value $0.001 per share
2024-03-28	Opaleye Management Inc.	Buy	50 000	Common Stock, par value $0.001 per share

INSIDER POWER
13.46
Last 96 transactions
Buy: 4 652 789 \| Sell: 3 289 598

Volumen Korrelation

Lang: -0.11 (neutral)

Kurz: 0.43 (neutral)

Signal:(56.872) Neutral

Harrow Health Inc Korrelation

10 Am meisten positiv korreliert
SY	0.94
BRIVU	0.939
ARTEU	0.939
ALSA	0.936
PPYAU	0.935
IOAC	0.935
LCAA	0.934
GPACU	0.934
ATEC	0.933
ALTR	0.933

10 Am meisten negativ korreliert
CSSEP	-0.947
GOOD	-0.946
NAKD	-0.933
JAGX	-0.932
PCSA	-0.931
SIDU	-0.93
VFF	-0.929
NARI	-0.925
ALXO	-0.924
XPDI	-0.924

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Harrow Health Inc Korrelation - Währung/Rohstoff

0.16
( neutral )

0.18
( neutral )

0.00
( neutral )

0.16
( neutral )

-0.65
( moderate negative )

0.00
( neutral )

Harrow Health Inc Finanzdaten

Annual	2023
Umsatz:	$130.19M
Bruttogewinn:	$90.55M (69.55 %)
EPS:	$-0.750

FY	2023
Umsatz:	$130.19M
Bruttogewinn:	$90.55M (69.55 %)
EPS:	$-0.750

FY	2022
Umsatz:	$88.60M
Bruttogewinn:	$63.21M (71.35 %)
EPS:	$-0.510

FY	2021
Umsatz:	$72.48M
Bruttogewinn:	$54.26M (74.87 %)
EPS:	$-0.690

Financial Reports:

No articles found.

Harrow Health Inc

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.